2013 Q4 Form 10-Q Financial Statement

#000119312513442262 Filed on November 14, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $96.20M $27.42M $9.897M
YoY Change 177.0%
Cost Of Revenue $62.70M $51.40M $18.30M
YoY Change 180.87%
Gross Profit $33.50M $27.40M $9.900M
YoY Change 176.77%
Gross Profit Margin 34.82% 99.95% 100.03%
Selling, General & Admin $30.60M $19.79M $8.850M
YoY Change 123.63%
% of Gross Profit 91.34% 72.23% 89.39%
Research & Development $1.400M
YoY Change
% of Gross Profit 14.14%
Depreciation & Amortization $800.0K $400.0K $0.00
YoY Change
% of Gross Profit 2.39% 1.46% 0.0%
Operating Expenses $30.70M $24.79M $10.78M
YoY Change 129.96%
Operating Profit $2.800M $2.613M -$879.0K
YoY Change -397.27%
Interest Expense $51.37M $18.26M
YoY Change 181.34%
% of Operating Profit 1965.94%
Other Income/Expense, Net
YoY Change
Pretax Income $2.900M $2.628M -$882.0K
YoY Change -397.96%
Income Tax $0.00 -$85.00K $0.00
% Of Pretax Income 0.0% -3.23%
Net Earnings $2.900M $2.713M -$882.0K
YoY Change -407.6%
Net Earnings / Revenue 3.01% 9.9% -8.91%
Basic Earnings Per Share -$0.09
Diluted Earnings Per Share $40.17K $37.40K -$0.09
COMMON SHARES
Basic Shares Outstanding 13.69M shares 53.31M shares 10.30M shares
Diluted Shares Outstanding 80.00M shares 10.30M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $49.30M $52.40M
YoY Change
Cash & Equivalents $49.30M $62.19M $52.41M
Short-Term Investments
Other Short-Term Assets $3.500M $1.100M
YoY Change
Inventory
Prepaid Expenses
Receivables $400.0K
Other Receivables $34.10M
Total Short-Term Assets $87.30M $58.00M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $12.60M $8.407M $1.100M
YoY Change 698.16% 664.27%
Goodwill $0.00
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments $200.0K $1.400M
YoY Change
Other Assets $12.20M $5.700M
YoY Change
Total Long-Term Assets $1.856B $611.3M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $87.30M $58.00M
Total Long-Term Assets $1.856B $611.3M
Total Assets $1.943B $1.612B $669.3M
YoY Change 128.41% 140.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.500M $800.0K
YoY Change
Accrued Expenses $26.90M $8.800M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.875B $617.9M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.875B $617.9M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.875B $1.550B $617.8M
YoY Change 134.82% 150.86%
SHAREHOLDERS EQUITY
Retained Earnings -$50.33M -$53.19M
YoY Change -12.68%
Common Stock $138.0K $136.0K
YoY Change 12.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $68.09M -$41.36M $51.60M
YoY Change
Total Liabilities & Shareholders Equity $1.943B $1.612B $669.3M
YoY Change 128.41% 140.8%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income $2.900M $2.713M -$882.0K
YoY Change -407.6%
Depreciation, Depletion And Amortization $800.0K $400.0K $0.00
YoY Change
Cash From Operating Activities -$15.10M $9.700M $2.100M
YoY Change 361.9%
INVESTING ACTIVITIES
Capital Expenditures -$2.700M -$3.700M -$500.0K
YoY Change 640.0%
Acquisitions
YoY Change
Other Investing Activities -$335.6M -$295.2M -$156.3M
YoY Change 88.87%
Cash From Investing Activities -$338.3M -$298.9M -$156.9M
YoY Change 90.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 340.4M 296.9M 159.9M
YoY Change 85.68%
NET CHANGE
Cash From Operating Activities -15.10M 9.700M 2.100M
Cash From Investing Activities -338.3M -298.9M -156.9M
Cash From Financing Activities 340.4M 296.9M 159.9M
Net Change In Cash -13.00M 7.700M 5.100M
YoY Change 50.98%
FREE CASH FLOW
Cash From Operating Activities -$15.10M $9.700M $2.100M
Capital Expenditures -$2.700M -$3.700M -$500.0K
Free Cash Flow -$12.40M $13.40M $2.600M
YoY Change 415.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13694815 shares
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52409000
CY2012Q3 ck0001409970 Minimum Origination Fee Charged
MinimumOriginationFeeCharged
0.0111 pure
CY2012Q3 ck0001409970 Maximum Origination Fee Charged
MaximumOriginationFeeCharged
0.0500 pure
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13601335 shares
CY2013Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
11449958 shares
CY2013Q3 us-gaap Preferred Stock Capital Shares Reserved For Future Issuance
PreferredStockCapitalSharesReservedForFutureIssuance
61617516 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.03
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9488881 shares
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.81
CY2013Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
9089708 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2013Q3 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
1 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
15859948 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.98
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
9089708 shares
CY2013Q3 us-gaap Treasury Stock Number Of Shares Held
TreasuryStockNumberOfSharesHeld
0 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13601335 shares
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
200000
CY2013Q3 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
1522975000
CY2013Q3 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
2500000
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11694000
CY2013Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
9475000
CY2013Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1522975000
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
-41357000
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53187000
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
103219000
CY2013Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
2330000
CY2013Q3 us-gaap Liabilities
Liabilities
1549786000
CY2013Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
14549000
us-gaap Fees And Commissions
FeesAndCommissions
19418000
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
136000
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1611648000
CY2013Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
1516676000
CY2013Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
15900000
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8407000
CY2013Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
8747000
CY2013Q3 us-gaap Assets
Assets
1611648000
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62186000
CY2013Q3 us-gaap Interest Receivable
InterestReceivable
12801000
CY2013Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
53000000
CY2013Q3 us-gaap Deposits Assets
DepositsAssets
253000
CY2013Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
2578000
CY2013Q3 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
1516676000
CY2013Q3 ck0001409970 Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice
0.76
CY2013Q3 ck0001409970 Actual Cash Pledged And Restricted To Support Contingent Obligation
ActualCashPledgedAndRestrictedToSupportContingentObligation
3400000
CY2013Q3 ck0001409970 Minimum Origination Fee Charged
MinimumOriginationFeeCharged
0.0111 pure
CY2013Q3 ck0001409970 Principal Amount Of Member Loan Before Fair Value Adjustment
PrincipalAmountOfMemberLoanBeforeFairValueAdjustment
1554553000
CY2013Q3 ck0001409970 Principal Amount Of Notes Before Fair Value Adjustment
PrincipalAmountOfNotesBeforeFairValueAdjustment
-1560823000
CY2013Q3 ck0001409970 Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingNumber
3125677 shares
CY2013Q3 ck0001409970 Funded Investment Commitments
FundedInvestmentCommitments
10000
CY2013Q3 ck0001409970 Number Of Board Of Directors Common Stockholders Are Entitled To Elect
NumberOfBoardOfDirectorsCommonStockholdersAreEntitledToElect
1 Director
CY2013Q3 ck0001409970 Maximum Origination Fee Charged
MaximumOriginationFeeCharged
0.0500 pure
CY2013Q3 ck0001409970 Majority Of Outstanding Shares Of Convertible Preferred Stock
MajorityOfOutstandingSharesOfConvertiblePreferredStock
0.55 pure
CY2013Q3 ck0001409970 Maximum Cash Pledged To Support Contingent Obligation
MaximumCashPledgedToSupportContingentObligation
5000000
CY2013Q3 ck0001409970 Preferred Stockholders Number Of Vote For Each Share Of Common Stock
PreferredStockholdersNumberOfVoteForEachShareOfCommonStock
1 Vote
CY2013Q3 ck0001409970 Payable To Member Investors
PayableToMemberInvestors
457000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24712000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11291862 shares
CY2012Q4 us-gaap Preferred Stock Capital Shares Reserved For Future Issuance
PreferredStockCapitalSharesReservedForFutureIssuance
61617516 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.19
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10255222 shares
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Treasury Stock Number Of Shares Held
TreasuryStockNumberOfSharesHeld
17640 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11291862 shares
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
785316000
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6713000
CY2012Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
3366000
CY2012Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
785316000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-50813000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57637000
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
103023000
CY2012Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
1210000
CY2012Q4 us-gaap Liabilities
Liabilities
798620000
CY2012Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
6678000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
123000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
850830000
CY2012Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
781215000
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
12000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1578000
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
7484000
CY2012Q4 us-gaap Assets
Assets
850830000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52551000
CY2012Q4 us-gaap Interest Receivable
InterestReceivable
5521000
CY2012Q4 us-gaap Deposits Assets
DepositsAssets
696000
CY2012Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
1785000
CY2012Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
781215000
CY2012Q4 ck0001409970 Payable To Member Investors
PayableToMemberInvestors
2050000
dei Entity Registrant Name
EntityRegistrantName
LENDINGCLUB CORP
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0001409970
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Servicing Asset At Amortized Value Period Increase Decrease
ServicingAssetAtAmortizedValuePeriodIncreaseDecrease
578000
us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.06 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y3M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0110 pure
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80160536 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
811956 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.635 pure
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.81
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.85 pure
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6792704 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Number Of Shares Period Increase Decrease
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease
1800000 shares
us-gaap Debt Instrument Interest Rate Effective Percentage Rate Range Minimum
DebtInstrumentInterestRateEffectivePercentageRateRangeMinimum
0.0603 pure
us-gaap Debt Instrument Maturity Date Description
DebtInstrumentMaturityDateDescription
Various maturity dates through September 2018
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
10.00
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
us-gaap Noninterest Income
NoninterestIncome
64490000
us-gaap Net Income Loss
NetIncomeLoss
4450000
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
4718000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.95
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
16202000
us-gaap Fiscal Period
FiscalPeriod
<div> <p style="MARGIN-TOP: 6pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b><i><u>Change in Fiscal Year</u></i></b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> On December&#xA0;19, 2012, our Board of Directors approved a change in our fiscal year-end from March&#xA0;31<sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: top">st</sup> to December&#xA0;31<sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: top">st</sup>. The change was effective as of December&#xA0;31, 2012 and we filed a transition report with the Securities and Exchange Commission (&#x201C;SEC&#x201D;), which covered the nine-month period ending December&#xA0;31, 2012. The accompanying interim condensed consolidated financial statements cover the period from January&#xA0;1, 2013 through September&#xA0;30, 2013, representing three quarters of our newly adopted fiscal year period and should be read in conjunction with our audited financial statements and notes thereto for the nine-month period ended December&#xA0;31, 2012.</p> </div>
us-gaap Debt Instrument Payment Terms
DebtInstrumentPaymentTerms
Monthly
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y2M19D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2100402 shares
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b><i><u>Concentrations of Credit Risk</u></i></b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, restricted cash, Member Loans financed directly by LendingClub and the related accrued interest receivable, and deposits with service providers. We hold our cash and cash equivalents and restricted cash in accounts at regulated domestic financial institutions. We are exposed to credit risk in the event of default by these institutions to the extent the amount recorded on the balance sheet exceeds the FDIC insured amounts. As of September&#xA0;30, 2013, the Company has net credit risk exposure on $0.4 million of fair value of Member Loans held that were financed directly by LendingClub.&#xA0; At September 30, 2012, we had net credit risk exposure on $0.5 million of fair value of Member Loans held that were financed directly by Lending Club.</p> </div>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b><i><u>Reclassifications</u></i></b></p> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt"> &#xA0;</p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> During the third quarter of 2013, we changed the definitions used to classify operating expenses. Operating expenses were formerly classified as Sales, marketing and customer service, Engineering, and General and administrative. Our new categories of operating expenses are Sales and marketing, Origination and servicing, and General and administrative. As a result of the new classification, loan origination and servicing costs which were previously included in Sales, marketing and customer service are now included as a separate financial statement line and engineering costs which represent technology related expenses are categorized within General and administrative expenses. The changes had no impact to the total operating expenses or net income. Prior period amounts have been reclassified to conform to the current presentation.</p> </div>
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
59941389 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
0.25 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.03
us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
The Company believes limitations exist only on the future annual deductibility of approximately $0.0 million of the Company's total net operating loss carryforwards
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600451 shares
us-gaap Debt Instrument Interest Rate Effective Percentage Rate Range Maximum
DebtInstrumentInterestRateEffectivePercentageRateRangeMaximum
0.2606 pure
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b><i><u>Use of Estimates</u></i></b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The preparation of our condensed consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make judgments, assumptions and estimates that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other factors we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of certain assets and liabilities. These judgments, assumptions and estimates include but are not limited to the following: (i)&#xA0;revenue recognition; (ii)&#xA0;fair value determinations for Member Loans, Notes and Certificates; (iii)&#xA0;stock-based compensation expense; (iv)&#xA0;provision for income taxes, net of valuation allowance for deferred tax assets; and (v)&#xA0;loan servicing asset/liability fair value determination. These judgments, estimates and assumptions are inherently subjective in nature and actual results may differ from these judgments, estimates and assumptions, and the differences could be material.</p> </div>
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.73
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1566750 shares
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y2M12D
us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
2100402 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12614487 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
232689 shares
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
0.01
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y2M16D
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
341256000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7736000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
1264000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
1115694000
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
-442000
us-gaap Interest Income Operating
InterestIncomeOperating
124771000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
250433000
us-gaap Management Fees Revenue
ManagementFeesRevenue
2082000
us-gaap Investment Advisory Management And Administrative Fees
InvestmentAdvisoryManagementAndAdministrativeFees
2082000
us-gaap Interest Paid
InterestPaid
116746000
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
24500000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
7280000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4450000
us-gaap Revenues
Revenues
64505000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
44000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
792000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
15000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
4718000
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1500000
us-gaap Servicing Fees Net
ServicingFeesNet
2461000
us-gaap Fees And Commissions
FeesAndCommissions
55229000
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
us-gaap Proceeds From Loans
ProceedsFromLoans
341256000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22433000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
775771000
us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
250433000
us-gaap Share Based Compensation
ShareBasedCompensation
3345000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
9635000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
26577000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1300000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
7871000
us-gaap Operating Expenses
OperatingExpenses
60055000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
137000
us-gaap Interest Expense
InterestExpense
124727000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1120000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1531000
us-gaap Undistributed Earnings Allocated To Participating Securities
UndistributedEarningsAllocatedToParticipatingSecurities
4450000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
907000
us-gaap Concentration Risk Credit Risk Financial Instrument Maximum Exposure
ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
400000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3300000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
339048000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-782338000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
30000000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues
1366207000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
5532000
ck0001409970 Related Party Investments
RelatedPartyInvestments
5080000
ck0001409970 Highly Liquid Investments Maturity Period
HighlyLiquidInvestmentsMaturityPeriod
P3M
ck0001409970 Fair Valuation Adjustments On Notes And Certificates
FairValuationAdjustmentsOnNotesAndCertificates
-37848000
ck0001409970 Share Based Compensation Arrangement By Sharebased Payment Award Options Grants In Period Grant Date Fair Value
ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue
21900000
ck0001409970 Payment Of Liquidation Preference Transfer Of Voting Power Threshold Maximum Percentage
PaymentOfLiquidationPreferenceTransferOfVotingPowerThresholdMaximumPercentage
0.50 pure
ck0001409970 Internal Revenue Code Ownership Change Limitation Period
InternalRevenueCodeOwnershipChangeLimitationPeriod
P3Y
ck0001409970 Related Party Deposits
RelatedPartyDeposits
1868000
ck0001409970 Related Party Withdrawals
RelatedPartyWithdrawals
317000
ck0001409970 Fair Valuation Adjustments Net
FairValuationAdjustmentsNet
29000
ck0001409970 Fair Value Assets Measured On Recurring Basis Loss Included In Investment Income
FairValueAssetsMeasuredOnRecurringBasisLossIncludedInInvestmentIncome
-37877000
ck0001409970 Fair Valuation Adjustments Member Loans At Fair Value
FairValuationAdjustmentsMemberLoansAtFairValue
-37877000
ck0001409970 Maximum Period For Loan Classified As Nonaccrual Loan
MaximumPeriodForLoanClassifiedAsNonaccrualLoan
P120D
ck0001409970 Share Based Compensation Arrangement By Share Based Payment Award Options Ratable Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRatablePeriod
Next 12 quarters thereafter
ck0001409970 Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainIncludedInEarnings
-37848000
ck0001409970 Proceeds From Origination Of Member Loans At Fair Value
ProceedsFromOriginationOfMemberLoansAtFairValue
1115774000
ck0001409970 Payments On Charged Off Notes And Certificates At Fair Value
PaymentsOnChargedOffNotesAndCertificatesAtFairValue
1139000
ck0001409970 Proceeds From Issuance Of Notes And Certificates At Fair Value
ProceedsFromIssuanceOfNotesAndCertificatesAtFairValue
1115694000
ck0001409970 Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0.050 pure
ck0001409970 Payments On Notes And Certificates At Fair Value
PaymentsOnNotesAndCertificatesAtFairValue
339048000
ck0001409970 Percentage Of Cumulative Stock Ownership Change
PercentageOfCumulativeStockOwnershipChange
0.50 pure
ck0001409970 Increase Decrease In Payable To Member Lenders And Investors
IncreaseDecreaseInPayableToMemberLendersAndInvestors
-1593000
ck0001409970 Servicing And Origination
ServicingAndOrigination
11045000
ck0001409970 Recoveries From Sale And Collection Of Charged Off Loans For Member Loans
RecoveriesFromSaleAndCollectionOfChargedOffLoansForMemberLoans
1180000
ck0001409970 Recoveries From Sale And Collection Of Charged Off Loans For Notes And Certificates
RecoveriesFromSaleAndCollectionOfChargedOffLoansForNotesAndCertificates
1139000
ck0001409970 Proceeds From Recoveries And Sale Of Charged Off Member Loans
ProceedsFromRecoveriesAndSaleOfChargedOffMemberLoans
1180000
ck0001409970 Payments For Proceeds From Origination Of Member Loans Sold
PaymentsForProceedsFromOriginationOfMemberLoansSold
250433000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9739922 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3301000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
68779184 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9739922 shares
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
764000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
1704000
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
513000
us-gaap Interest Income Operating
InterestIncomeOperating
44704000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6030000
us-gaap Management Fees Revenue
ManagementFeesRevenue
476000
us-gaap Investment Advisory Management And Administrative Fees
InvestmentAdvisoryManagementAndAdministrativeFees
476000
us-gaap Interest Paid
InterestPaid
38092000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
4123000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6030000
us-gaap Revenues
Revenues
21776000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
482000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
568000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
286000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
42000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
255000
us-gaap Noninterest Income
NoninterestIncome
21490000
us-gaap Net Income Loss
NetIncomeLoss
-6030000
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
255000
us-gaap Servicing Fees Net
ServicingFeesNet
1341000
us-gaap Proceeds From Loans
ProceedsFromLoans
131061000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10517000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
356269000
us-gaap Share Based Compensation
ShareBasedCompensation
779000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
27697000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12151000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-33000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
400000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
5060000
us-gaap Operating Expenses
OperatingExpenses
27806000
us-gaap Interest Expense
InterestExpense
44222000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
16000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
487000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
182000
us-gaap Concentration Risk Credit Risk Financial Instrument Maximum Exposure
ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
500000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
800000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-325271000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1741000
ck0001409970 Payments On Loans Payable
PaymentsOnLoansPayable
810000
ck0001409970 Fair Valuation Adjustments On Notes And Certificates
FairValuationAdjustmentsOnNotesAndCertificates
-15322000
ck0001409970 Fair Valuation Adjustments Net
FairValuationAdjustmentsNet
230000
ck0001409970 Fair Valuation Adjustments Member Loans At Fair Value
FairValuationAdjustmentsMemberLoansAtFairValue
-15551000
ck0001409970 Proceeds From Origination Of Member Loans At Fair Value
ProceedsFromOriginationOfMemberLoansAtFairValue
454080000
ck0001409970 Payments On Charged Off Notes And Certificates At Fair Value
PaymentsOnChargedOffNotesAndCertificatesAtFairValue
219000
ck0001409970 Proceeds From Issuance Of Notes And Certificates At Fair Value
ProceedsFromIssuanceOfNotesAndCertificatesAtFairValue
461961000
ck0001409970 Payments On Notes And Certificates At Fair Value
PaymentsOnNotesAndCertificatesAtFairValue
131772000
ck0001409970 Increase Decrease In Payable To Member Lenders And Investors
IncreaseDecreaseInPayableToMemberLendersAndInvestors
2859000
ck0001409970 Servicing And Origination
ServicingAndOrigination
5138000
ck0001409970 Proceeds From Recoveries And Sale Of Charged Off Member Loans
ProceedsFromRecoveriesAndSaleOfChargedOffMemberLoans
216000
ck0001409970 Provision Recoveries For Loan And Lease Losses
ProvisionRecoveriesForLoanAndLeaseLosses
-33000
CY2012 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
23900000
CY2012 ck0001409970 Related Party Investments
RelatedPartyInvestments
3144000
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10300351 shares
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
68991793 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10300351 shares
CY2012Q3 us-gaap Interest Income Operating
InterestIncomeOperating
18490000
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-882000
CY2012Q3 us-gaap Management Fees Revenue
ManagementFeesRevenue
225000
CY2012Q3 us-gaap Investment Advisory Management And Administrative Fees
InvestmentAdvisoryManagementAndAdministrativeFees
225000
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-882000
CY2012Q3 us-gaap Revenues
Revenues
9897000
CY2012Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
231000
CY2012Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
83000
CY2012Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
137000
CY2012Q3 us-gaap Noninterest Income
NoninterestIncome
9814000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-882000
CY2012Q3 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
137000
CY2012Q3 us-gaap Servicing Fees Net
ServicingFeesNet
479000
CY2012Q3 us-gaap Fees And Commissions
FeesAndCommissions
8973000
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4107000
CY2012Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4743000
CY2012Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
7000
CY2012Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
100000
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
10779000
CY2012Q3 us-gaap Interest Expense
InterestExpense
18259000
CY2012Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
300000
CY2012Q3 ck0001409970 Fair Valuation Adjustments On Notes And Certificates
FairValuationAdjustmentsOnNotesAndCertificates
-7107000
CY2012Q3 ck0001409970 Fair Valuation Adjustments Member Loans At Fair Value
FairValuationAdjustmentsMemberLoansAtFairValue
-7248000
CY2012Q3 ck0001409970 Servicing And Origination
ServicingAndOrigination
1929000
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80346432 shares
CY2013Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
509163 shares
CY2013Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6482703 shares
CY2013Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
60026463 shares
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1148679 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13328103 shares
CY2013Q3 us-gaap Interest Income Operating
InterestIncomeOperating
51386000
CY2013Q3 us-gaap Management Fees Revenue
ManagementFeesRevenue
869000
CY2013Q3 us-gaap Investment Advisory Management And Administrative Fees
InvestmentAdvisoryManagementAndAdministrativeFees
869000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2628000
CY2013Q3 us-gaap Revenues
Revenues
27415000
CY2013Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
16000
CY2013Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
10000
CY2013Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
349000
CY2013Q3 us-gaap Noninterest Income
NoninterestIncome
27405000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
2713000
CY2013Q3 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
349000
CY2013Q3 us-gaap Servicing Fees Net
ServicingFeesNet
942000
CY2013Q3 us-gaap Fees And Commissions
FeesAndCommissions
25245000
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9331000
CY2013Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10460000
CY2013Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
24787000
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-85000
CY2013Q3 us-gaap Interest Expense
InterestExpense
51370000
CY2013Q3 us-gaap Undistributed Earnings Allocated To Participating Securities
UndistributedEarningsAllocatedToParticipatingSecurities
2713000
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1900000
CY2013Q3 ck0001409970 Fair Valuation Adjustments On Notes And Certificates
FairValuationAdjustmentsOnNotesAndCertificates
-15607000
CY2013Q3 ck0001409970 Fair Valuation Adjustments Member Loans At Fair Value
FairValuationAdjustmentsMemberLoansAtFairValue
-15613000
CY2013Q3 ck0001409970 Servicing And Origination
ServicingAndOrigination
4996000

Files In Submission

Name View Source Status
0001193125-13-442262-index-headers.html Edgar Link pending
0001193125-13-442262-index.html Edgar Link pending
0001193125-13-442262.txt Edgar Link pending
0001193125-13-442262-xbrl.zip Edgar Link pending
ck0001409970-20130930.xml Edgar Link completed
ck0001409970-20130930.xsd Edgar Link pending
ck0001409970-20130930_cal.xml Edgar Link unprocessable
ck0001409970-20130930_def.xml Edgar Link unprocessable
ck0001409970-20130930_lab.xml Edgar Link unprocessable
ck0001409970-20130930_pre.xml Edgar Link unprocessable
d595288d10q.htm Edgar Link pending
d595288dex311.htm Edgar Link pending
d595288dex312.htm Edgar Link pending
d595288dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g5952881.jpg Edgar Link pending
g5952882.jpg Edgar Link pending
g5952883.jpg Edgar Link pending
g5952884.jpg Edgar Link pending
g5952885.jpg Edgar Link pending
g5952886.jpg Edgar Link pending
g5952887.jpg Edgar Link pending
g5952888.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending